Trial Profile
A Phase II trial of 2X-121 in castration resistant prostate cancer
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Stenoparib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Jul 2018 New trial record